drugset / Trial / NCT04939077

Treatment of Heart Failure Using Human Umbilical Cord Mesenchymal Stem Cells(hUC-MSC)

NCT04939077 ↗

Phase 1/2 Unknown 20 enrolled Shanghai East Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

This study is an exploratory clinical study to observe the improvement of heart function before and after the treatment by human umbilical cord mesenchymal stem cells, and the purpose is to evaluate the safety and effectiveness of human umbilical cord mesenchymal stem cells in the treatment of heart failure. The study is a randomized parallel controlled study. Patients receive a review of which main content includes symptom improvement, cardiac function improvement, and adverse events.

Timeline

Start
2019-11-27
Primary completion
2022-07-31
Completion
2022-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Allogeneic Human Umbilical Cord Mesenchymal Stem Cells Cell therapy 1e+07 cells Other